Clinical Trials - BEAM

NCT IDTitleStatusPhasesStart DateCompletion DatePrimary Completion Date
NCT06735755A Phase 1/2, Dose-Exploration Study to Evaluate the Safety and Efficacy of BEAM-301 in Patients With Glycogen Storage Disease Type Ia (GSDIa)RECRUITINGPHASE1, PHASE22024-12-062027-12-302027-12-30
NCT07183735A Crossover Trial to Examine the Efficacy of a Powder to Improve Sleep Quality and PerformanceCOMPLETEDNA2024-07-022024-10-172024-10-17
NCT06389877A Study to Evaluate the Safety and Efficacy of BEAM-302 in Adult Patients With Alpha-1 Antitrypsin Deficiency (AATD)RECRUITINGPHASE1, PHASE22024-06-192027-082027-06
NCT05885464A Study Evaluating the Safety and Efficacy of BEAM-201 in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LL)ACTIVE_NOT_RECRUITINGPHASE1, PHASE22023-05-252026-122026-12
NCT05456880BEACON: A Study Evaluating the Safety and Efficacy of BEAM-101 in Patients With Severe Sickle Cell DiseaseRECRUITINGPHASE1, PHASE22022-08-302027-02-012025-02-01
NCT05521243An Exploratory Investigation of a Supplement to Enhance Sleep Quality and QuantityCOMPLETEDNA2022-05-092022-09-302022-09-30